Lipoprotein (a): genetic marker for atherosclerosis?
作者信息
Breckenridge W C
机构信息
Department of Biochemistry, Dalhousie University, Halifax, NS.
出版信息
CMAJ. 1990 Jul 15;143(2):115.
Abstract
摘要
相似文献
1
Lipoprotein (a): genetic marker for atherosclerosis?脂蛋白(a)：动脉粥样硬化的遗传标志物？
CMAJ. 1990 Jul 15;143(2):115.
2
PCR methodology applied to genetic studies of lipoprotein metabolism and atherosclerosis.
Methods Mol Biol. 1998;110:1-34. doi: 10.1385/1-59259-582-0:1.
3
Lipoprotein(a) and atherosclerosis.脂蛋白(a)与动脉粥样硬化
Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):1-2. doi: 10.1161/01.atv.21.1.1.
4
Genetic polymorphisms and atherosclerosis.基因多态性与动脉粥样硬化。
Monogr Atheroscler. 1986;14:113-8.
5
6
[Apolipoproteins in atherosclerosis].
Clin Ter. 1984 Sep 15;110(5):477-82.
7
Mapping of lipoprotein particles with monoclonal antibodies in diabetes and atherosclerosis.利用单克隆抗体对糖尿病和动脉粥样硬化中的脂蛋白颗粒进行图谱分析。
Monogr Atheroscler. 1985;13:134-41.
8
Lipoprotein(a) concentration and apolipoprotein(a) size: A synergistic role in advanced atherosclerosis?脂蛋白(a)浓度与载脂蛋白(a)大小：在晚期动脉粥样硬化中起协同作用？
Circulation. 1999 Sep 14;100(11):1151-3. doi: 10.1161/01.cir.100.11.1151.
9
[Lipoprotein(a)--atherogenic waste product of evolution?].[脂蛋白(a)——进化产生的致动脉粥样硬化废物？]
Wien Med Wochenschr. 1994;144(12-13):324-30.
10
Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility.
Genet Epidemiol. 1987;4(3):163-84. doi: 10.1002/gepi.1370040302.
引用本文的文献
1
Telomere length and replicative aging in human vascular tissues.人类血管组织中的端粒长度与复制性衰老
Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11190-4. doi: 10.1073/pnas.92.24.11190.
2
Gene-environment interactions and atherosclerosis.基因-环境相互作用与动脉粥样硬化
CMAJ. 1990 Dec 15;143(12):1332.
本文引用的文献
1
Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population.加拿大在职人群的血浆脂蛋白水平及高脂蛋白血症患病率
Can Med Assoc J. 1980 Jan 12;122(1):37-8, 40-6.
2
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.人类载脂蛋白(a)的cDNA序列与纤溶酶原同源。
Nature. 1987;330(6144):132-7. doi: 10.1038/330132a0.
3
Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a).从人脂蛋白（a）中分离载脂蛋白（a）并进行部分特性鉴定。
Biochem Cell Biol. 1986 Oct;64(10):999-1009. doi: 10.1139/o86-133.
4
Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment.脂蛋白Lp(a)的水平在接受新霉素和烟酸治疗后会下降。
Atherosclerosis. 1985 Nov;57(2-3):293-301. doi: 10.1016/0021-9150(85)90041-3.
5
Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.血浆中载脂蛋白(a) [Ip(a)] 浓度与载脂蛋白(a) [apo(a)] 基因中kringle IV/kringle V编码结构域的比例呈负相关。
J Clin Invest. 1989 Dec;84(6):2021-7. doi: 10.1172/JCI114395.
6
Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site.细胞纤溶酶原结合位点的进一步特征：纤溶酶原2和脂蛋白a竞争同一位点的证据。
Biochemistry. 1989 Mar 21;28(6):2374-7. doi: 10.1021/bi00432a005.
7
The mysteries of lipoprotein(a).脂蛋白(a)的奥秘。
Science. 1989 Nov 17;246(4932):904-10. doi: 10.1126/science.2530631.
Zotero 插件